{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/648536096",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1645664101"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#648536096",
  "code": "KA62.7",
  "source": "http://id.who.int/icd/entity/648536096",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Congenital parvovirus syndrome"
  },
  "definition": {
    "@language": "en",
    "@value": "Fetal parvovirus syndrome is a fetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Fetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and fetal death by cardiac failure in 10 to 20% of cases."
  },
  "longDefinition": {
    "@language": "en",
    "@value": "Foetal parvovirus syndrome is a foetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Foetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and foetal death by cardiac failure in 10 to 20% of cases. A congenitally acquired parvovirus infection is often asymptomatic in the mother. The infection in the fetus however can lead to serious disease commonly characterized by fetal hydrops and serious multiorgan injury"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Congenital parvovirus syndrome"
      }
    }
  ]
}